Immunogenicity of a two‐dose regime of varicella vaccine in children with cancers

Objective:  Live‐attenuated varicella vaccine is effective and safe in immunocompetent children. In this study, we assess the immunogenicity and adverse events following varicella vaccination in immunosuppressed cancer children.

[1]  A. Arvin,et al.  Use of an inactivated varicella vaccine in recipients of hematopoietic-cell transplants. , 2002, The New England journal of medicine.

[2]  L. Mascola,et al.  Varicella disease after introduction of varicella vaccine in the United States, 1995-2000. , 2002, JAMA.

[3]  P. Chan,et al.  Incidence, risk factors and outcome of varicella-zoster virus infection in children after haematopoietic stem cell transplantation , 2000, Bone Marrow Transplantation.

[4]  M. Knuf,et al.  Cellular immune response of a varicella vaccine following simultaneous DTaP and VZV vaccination. , 1999, Vaccine.

[5]  Chi-kong Li,et al.  Transfusion‐Related Immunomodulation in Chinese Children with Thalassaemia , 1997, Vox sanguinis.

[6]  P. LaRussa,et al.  Varicella vaccine for immunocompromised children: results of collaborative studies in the United States and Canada. , 1996, The Journal of infectious diseases.

[7]  J. Gratama,et al.  Identification of an unusual Fc gamma receptor IIIa (CD16) on natural killer cells in a patient with recurrent infections. , 1996, Blood.

[8]  M. Levin,et al.  Varicella zoster virus-specific cytotoxicity following secondary immunization with live or killed vaccine. , 1996, Viral immunology.

[9]  M. Halloran,et al.  Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.

[10]  A. Arvin.  Cell-mediated immunity to varicella-zoster virus. , 1992, The Journal of infectious diseases.

[11]  B T Grenfell,et al.  The epidemiology of varicella–zoster virus infections: a mathematical model , 1992, Epidemiology and Infection.

[12]  A. Gershon.  Viral vaccines of the future. , 1990, Pediatric clinics of North America.

[13]  A. Gershon,et al.  Live attenuated varicella vaccine: protection in healthy adults compared with leukemic children. National Institute of Allergy and Infectious Diseases Varicella Vaccine Collaborative Study Group. , 1990, The Journal of infectious diseases.

[14]  J L Sullivan,et al.  Severe herpesvirus infections in an adolescent without natural killer cells. , 1989, The New England journal of medicine.

[15]  E. Hunter,et al.  T lymphocyte cytotoxicity with natural varicella-zoster virus infection and after immunization with live attenuated varicella vaccine. , 1989, Journal of Immunology.

[16]  D. Miller,et al.  Cooperation between CD16(Leu-11b)+ NK cells and HLA-DR+ cells in natural killing of herpesvirus-infected fibroblasts. , 1987, Journal of immunology.

[17]  S. Feldman,et al.  Varicella in children with cancer: impact of antiviral therapy and prophylaxis. , 1987, Pediatrics.

[18]  R. A. Coward,et al.  Severe haemorrhage from a lumbar artery as a complication of percutaneous renal biopsy. , 1985, Postgraduate medical journal.

[19]  H. Holtmann,et al.  Active immunization against varicella of children with acute leukaemia or other malignancies on maintenance chemotherapy. , 1985, Postgraduate medical journal.